# FDA Inspection 1152220 - Regenerative Biologics Inc - September 15, 2021

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/93629d29-95ec-40bb-8d33-405292bc75a1
Source feed: FDA_Inspections

> FDA Inspection 1152220 for Regenerative Biologics Inc on September 15, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1152220
- Company Name: Regenerative Biologics Inc
- Inspection Date: 2021-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/776bb559-0cd8-49f2-9ecf-49ba0a31ab19

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d